Levamlodipine besylate tablets
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HEBEI RENHE YIKANG PHARMA
- Publication Date
- 2012-09-19
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmacy, in particular to a levamlodipine besylate tablet. Background technique
[0002] Levoamlodipine besylate, namely (-) 3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro -6-Methyl-3,5-pyridinedicarboxylate benzenesulfonate is a calcium channel blocker, which blocks extracellular calcium ions from cardiac muscle and vascular smooth muscle from entering cells through the calcium channel (slow channel) of the cell membrane, Direct relaxation of vascular smooth muscle, has antihypertensive effect. The mechanism of action of this product for relieving angina pectoris has not been fully determined, but it can reduce myocardial ischemia through the following effects: expand peripheral arterioles, reduce peripheral resistance (afterload), thereby reducing myocardial energy consumption and oxygen demand; normal expansion and ischemia The coronary arteries and coronary arterioles in the region i...